U.S. Stem Cells Market Foreseen To Increase Exponentially By 2030

 U.S. Stem Cells Market Summary

The U.S. stem cells market size was valued at USD 5.46 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 9.46% from 2024 to 2030. The market growth is supported by the rising acceptance of regenerative medicine, along with an increasing number of regulatory approvals for stem cell therapies. The growing demand for regenerative treatments, coupled with rising healthcare expenditure, has further strengthened market prospects. Additionally, the increasing prevalence of genetic disorders and cancer has generated significant demand for innovative therapies. Moreover, stem cell preservation for future medical use, facilitated through public and private umbilical cord and tissue banking, has proven to be highly beneficial and continues to gain strong acceptance, thereby adding momentum to the market expansion.

In 2023, the U.S. accounted for more than 32.4% of the global stem cells market. The region’s dominance is attributed to rapid advancements in precision medicine, the establishment of advanced cell therapy production facilities, and the increasing number of clinical trials. Recent innovations in stem cell therapeutics and tissue engineering have paved the way for promising treatments for multiple diseases, ranging from cancer to rare genetic conditions. Furthermore, rising demand for stem cell banking and intensified research efforts in stem cell production, storage, and characterization are likely to enhance revenue generation. Technological innovations in both primary applications and supporting industries related to stem cell use are also expected to accelerate the demand throughout the forecast period.

Key Market Trends & Insights

  • The regenerative medicine segment led the market and secured the highest revenue share of 85.46% in 2023. This dominance is primarily due to the widespread adoption of regenerative therapies and the ongoing development of companion diagnostics and personalized medicine, especially in oncology and chronic disease management.
  • Among stem cell types, adult stem cells accounted for the largest market share of 71.77% in 2023. Their dominance is linked to the absence of ethical controversies associated with embryonic stem cells and the reduced risk of graft rejection, which makes them more acceptable for therapeutic use.
  • Based on process, cell acquisition emerged as the leading segment with the largest revenue share of 33.69% in 2023 and is anticipated to grow at the fastest CAGR during the forecast period. The introduction of embryonic stem cells has broadened treatment possibilities due to their pluripotent ability to transform into different cell types, thereby offering significant therapeutic potential.
  • On the basis of transplantation type, the allogenic segment dominated with the largest revenue share of 59.28% in 2023. Growth in this category is primarily driven by the high costs associated with stem cell therapies and the expansion of stem cell banking. Furthermore, there is a noticeable industry shift toward the development of allogenic cell therapy products by various biotechnology and cell therapy companies, which is expected to substantially support segment growth in the years ahead.
  • Pharmaceutical and biotechnology companies held the largest market share of 53.0% in 2023 and are projected to expand at the fastest CAGR from 2024 to 2030. This leadership is fueled by the rising prevalence of chronic diseases, a steady increase in clinical trials, greater investment in strategic collaborations, and significant improvements in healthcare infrastructure and services.

Order a free sample PDF of the U.S. Stem Cells Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

  • 2023 Market Size: USD 5.46 billion
  • 2030 Projected Market Size: USD 10.39 billion
  • CAGR (2024 - 2030): 9.46%

Key Companies & Market Share Insights

The U.S. stem cells market is characterized by the existence of both established companies and startups that concentrate on specialized therapeutics. Major market participants are innovating new products and engaging in partnerships to expand their product range, customer base, and global footprint. These tactics are anticipated to stimulate market growth in the future as more competitors join the market and strive to consolidate their market standing. Notable market players include Pluristem Therapeutics, Inc., STEMCELL Technologies, Inc., Bristol-Myers Squibb, Lisata Therapeutics, Cellular Engineering Technologies, Lineage Cell Therapeutics, BrainStorm Cell Therapeutics, among others.

Key Players

  • Thermo Fisher Scientific, Inc.
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • CellGenix GmbH
  • PromoCell GmbH
  • Takara Bio
  • Lonza
  • Cellartis AB
  • ATCC
  • AcceGen

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. stem cells market is witnessing rapid expansion, driven by advancements in regenerative medicine, increased regulatory approvals, and growing investment in research and clinical trials. With the country holding a strong global share, the focus on precision medicine, stem cell banking, and tissue engineering continues to create new growth avenues. Key segments such as adult stem cells, regenerative medicine, and pharmaceutical companies are positioned to lead the market, supported by high adoption rates and technological progress. Moving forward, the combined impact of innovation, healthcare spending, and expanding applications of stem cells will significantly strengthen the industry’s long-term outlook.

Comments

Post a Comment

Popular posts from this blog

Home And Laundry Care Industry Growth, Size, Share, Trends & Forecast

  Home And Laundry Care Industry The global  home and laundry care market  size is expected to reach USD 321.51 billion by 2030, registering a CAGR of 6.8% from 2022 to 2030, according to a new report by Grand View Research, Inc. The growing population in developing economies such as Brazil, India, and China is boosting the demand for laundry and home care products. This market has noteworthy potential growth in the coming years owing to increasing awareness regarding the benefits of laundry and home care products such as hygiene and cleanliness products among consumers. Major market players are introducing innovative cleaners for laundry and homes in terms of quality, packaging, and fragrance. Similarly, they are launching eco-friendly cleaning products in the market. Also, they are introducing innovative cleaning infused with natural ingredients to advance the effectiveness of the product. For instance, in October 2021, Unilever South Africa launched a dishwashing liqui...
Read more

Asia Pacific Medical Device Cleaning Market Worth $8.12 Billion By 2028

Asia Pacific Medical Device Cleaning Industry Overview The Asia Pacific medical device cleaning market size was valued at USD 3.22 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.2% from 2021 to 2028. The increasing prevalence of Hospital-acquired Infections (HAIs) coupled with the unprecedented surge in COVID-19 cases has fueled the demand for medical device cleaning products in the Asia Pacific (APAC) region. The rising prevalence of surgical site infections, the introduction of technologically advanced products, and growing government initiatives for spreading awareness about hygiene and cleanliness are a few more factors contributing to the market growth. Gather more insights about the market drivers, restrains and growth of the  Asia Pacific Medical Device Cleaning Market According to the Worldometer data, around 54,768,360 COVID-19 cases were reported in the Asia Pacific countries, on June 23 rd , 2021. Out of which, 1,829,004 were...
Read more

Healthcare Contract Development And Manufacturing Organization Market Worth $471.0 Billion By 2030

Healthcare Contract Development And Manufacturing Organization Industry Overview The global healthcare contract development and manufacturing organization market size was valued at USD 217.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030.  An increase in uptake of outsourcing services by pharmaceutical companies and growth in R&D investments are expected to drive the market. Medical devices & pharmaceutical companies are outsourcing low-end services to reduce the overall cost of production. This trend is expected to contribute to the growth of the market for healthcare contract development and manufacturing organization (CDMO), in the forecast period. The presence of end-to-end service providers that offer value-added services for an integrated or risk-sharing business model is expected to bolster market growth. The COVID-19 pandemic has significantly impacted the global economy in 2020 and has had an ongoing i...
Read more